Who owns Caris Life Sciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CAI from SEC Form 13F filings across 247 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 247 institutions disclosed 154.3M shares of Caris Life Sciences, Inc. worth $2.75B — about 54.6% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
247
13F holders
$2.75B
value, 2026 filers
54.6%
of shares outstanding (154.3M sh)
71
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CAI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 30.9M | $551.1M | 0.0% | 10.9% | +0.4% |
| 2 | J. H. Whitney Equity Partners VI, LLC | 11.3M | $200.6M | 100.0% | 4% | -38.3% |
| 3 | COATUE MANAGEMENT LLC | 9.8M | $175.0M | 0.4% | 3.5% | 0.0% |
| 4 | BRAIDWELL LP | 8.3M | $147.1M | 5.4% | 2.9% | +3.1% |
| 5 | Sixth Street Partners Management Company, L.P. | 7.3M | $130.6M | 22.5% | 2.6% | -49.1% |
| 6 | PointState Capital LP | 6.8M | $121.7M | 1.6% | 2.4% | -7.2% |
| 7 | JPMORGAN CHASE & CO | 6.6M | $120.2M | 0.0% | 2.3% | +89.5% |
| 8 | BlackRock, Inc. | 5.5M | $98.7M | 0.0% | 2% | +14.0% |
| 9 | T. Rowe Price Investment Management, Inc. | 5.1M | $90.5M | 0.1% | 1.8% | -9.1% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8M | $86.3M | 0.0% | 1.7% | +28.9% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3M | $76.3M | 0.0% | 1.5% | +28.6% |
| 12 | LOS ANGELES CAPITAL MANAGEMENT LLC | 4.0M | $70.5M | 0.3% | 1.4% | +72.9% |
| 13 | NEUBERGER BERMAN GROUP LLC | 3.6M | $64.0M | 0.0% | 1.3% | 0.0% |
| 14 | ORBIMED ADVISORS LLC | 2.8M | $50.0M | 0.9% | 1% | 0.0% |
| 15 | BNP PARIBAS FINANCIAL MARKETS | 2.4M | $42.2M | 0.0% | 0.8% | +46.8% |
| 16 | MILLENNIUM MANAGEMENT LLC | 2.2M | $39.3M | 0.0% | 0.8% | +44.2% |
| 17 | MAK CAPITAL ONE LLCNEW | 1.9M | $34.5M | 4.8% | 0.7% | new |
| 18 | MORGAN STANLEY | 1.9M | $34.5M | 0.0% | 0.7% | +79.3% |
| 19 | Duquesne Family Office LLC | 1.9M | $33.8M | 0.6% | 0.7% | 0.0% |
| 20 | Clearbridge Investments, LLC | 1.6M | $28.4M | 0.0% | 0.6% | +2.8% |
| 21 | FIL Ltd | 1.5M | $27.6M | 0.0% | 0.5% | +0.2% |
| 22 | UBS Group AG | 1.4M | $25.4M | 0.0% | 0.5% | -48.2% |
| 23 | HRT FINANCIAL LPNEW | 1.4M | $25.3M | 0.0% | 0.5% | new |
| 24 | CANADA PENSION PLAN INVESTMENT BOARD | 1.4M | $24.5M | 0.0% | 0.5% | +3.9% |
| 25 | Amundi | 1.2M | $21.7M | 0.0% | 0.4% | +5709.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.